280
Views
33
CrossRef citations to date
0
Altmetric
Expert Opinion

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation

, , , , , , , & show all
Pages 515-525 | Published online: 11 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Georg Rüdiger Schramm, Behrouz Mostafavi, Eeva Piitulainen, Per Wollmer & Hanan A Tanash. (2021) Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3477-3485.
Read now
Claudio Tantucci & Laura Pini. (2020) Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 821-829.
Read now
Matevz Harlander, Miriam Barrecheguren, Matjaz Turel & Marc Miravitlles. (2017) Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 465-468.
Read now
Marco Antonio Ponce-Gallegos, Alejandra Ramírez-Venegas & Ramcés Falfán-Valencia. (2017) Th17 profile in COPD exacerbations. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1857-1865.
Read now
Miguel Angel Martinez-Garcia & Marc Miravitlles. (2017) Bronchiectasis in COPD patients: more than a comorbidity?. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1401-1411.
Read now
Daniel Huertas, Concepción Montón, Alicia Marín, Ingrid Solanes, Marta López-Sánchez, Xavier Pomares, Mariana Muñoz-Esquerre, Jordi Dorca & Salud Santos. (2017) Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:3, pages 304-310.
Read now
Kai-Michael Beeh, Jutta Beier, Henning Candler & Thomas Wittig. (2016) Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype – a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2877-2884.
Read now

Articles from other publishers (26)

Élise Fortin, Caroline Sirois, Caroline Quach, Sonia Jean, Marc Simard, Marc Dionne, Alejandra Irace-Cima & Nadine Magali-Ufitinema. (2022) Chronic diseases and variations in rates of antimicrobial use in the community: a population-based analysis of linked administrative data in Quebec, Canada, 2002–2017. CMAJ Open 10:3, pages E831-E840.
Crossref
Vincenzo Sorrenti, Francesca Benedetti, Alessandro Buriani, Stefano Fortinguerra, Giada Caudullo, Sergio Davinelli, Davide Zella & Giovanni Scapagnini. (2022) Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks. Pharmaceuticals 15:8, pages 912.
Crossref
Saminan Saminan, Linda Julisafrida, Muhammad Ridwan & Nurul Fajri. (2022) COVID-19 Pandemic: What Considerations Should Be Taken during the Assessment and Management of COPD Exacerbation?. Open Access Macedonian Journal of Medical Sciences 10:F, pages 71-80.
Crossref
Laura V. Reid, C. Mirella Spalluto, Alastair Watson, Karl J. Staples & Tom M. A. Wilkinson. (2021) The Role of Extracellular Vesicles as a Shared Disease Mechanism Contributing to Multimorbidity in Patients With COPD. Frontiers in Immunology 12.
Crossref
Paolo Groff, Giuseppina Petrelli, Paolo Giorgini, Roberto Pilotti, Vito Maurizio Parato & Andrea Fabbri. (2021) Clinical heterogeneity of a population of patients admitted to the Emergency Department with a diagnosis of COPD-exacerbation: Relevance of cardiovascular comorbidities. Emergency Care Journal 17:1.
Crossref
Abulajiang Tuoheti, Xingzhi Gu, Xiuqin Cheng & Hua Zhang. (2020) Silencing Nrf2 attenuates chronic suppurative otitis media by inhibiting pro-inflammatory cytokine secretion through up-regulating TLR4. Innate Immunity 27:1, pages 70-80.
Crossref
Francesca Benedetti, Vincenzo Sorrenti, Alessandro Buriani, Stefano Fortinguerra, Giovanni Scapagnini & Davide Zella. (2020) Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways. Viruses 12:12, pages 1458.
Crossref
David de la Rosa Carrillo, José Luís López-Campos, Bernardino Alcázar Navarrete, Myriam Calle Rubio, Rafael Cantón Moreno, Juan Luis García-Rivero, Luís Máiz Carro, Casilda Olveira Fuster, Miguel Ángel Martínez-García, Francisco Javier Callejas, Ángela Cervera Juan, Marta Palop Cervera, Antonia Fuster Gomila, Alicia Marín Tapia, Xavier Pomares Amigo, Mirian Torres González, Jacinto Hernández Borge, Gerardo Pérez Chica, Rocío Jimeno Galván, Rafael Golpe Gómez, Pedro J. Marcos Rodríguez, Pilar Cebollero Rivas, Eva Tabernero Huguet, Carlos Álvarez Martínez, Concha Prados Sánchez, José Javier Martínez Garcerán, Carlos Peñalver Mellado, Marta García Clemente, Juan Rodríguez López, Juan Marco Figueira Gonçalves, Guillermo José Pérez Mendoza, Jesús Hernández Hernández, Carlos Amado Diago, Laura Pérez Giménez, Virginia Moya Álvarez, Alexandre Palou Rotger, Rosa Girón Moreno, Marina Blanco Aparicio, Annie Navarro Rolón, Oriol Sibila, Marc Miravitlles Fernández, Juan José Soler Cataluña, José Alberto Fernández Villar & Germán Peces-Barba Romero. (2020) Documento de consenso sobre el diagnóstico y tratamiento de la infección bronquial crónica en la enfermedad pulmonar obstructiva crónica. Archivos de Bronconeumología 56:10, pages 651-664.
Crossref
David de la Rosa Carrillo, José Luís López-Campos, Bernardino Alcázar Navarrete, Myriam Calle Rubio, Rafael Cantón Moreno, Juan Luis García-Rivero, Luís Máiz Carro, Casilda Olveira Fuster & Miguel Ángel Martínez-García. (2020) Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease. Archivos de Bronconeumología (English Edition) 56:10, pages 651-664.
Crossref
Élise Fortin, Sonia Jean, Caroline Sirois, Marc Simard, Alejandra Irace-Cima, Valérie Émond & Marc Dionne. (2020) Chronic respiratory disease should be considered when interpreting indicators of community antimicrobial use in people over 65 years old. Canadian Journal of Public Health 111:3, pages 443-447.
Crossref
José Luis Lopez-Campos, Marc Miravitlles, David de la Rosa Carrillo, Rafael Cantón, Juan Jose Soler-Cataluña & Miguel Angel Martinez-Garcia. (2020) Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 9:6, pages 1639.
Crossref
Chen Long, Yandong Lai, Tiao Li, Toru Nyunoya & Chunbin Zou. (2020) Cigarette smoke extract modulates Pseudomonas aeruginosa bacterial load via USP25/HDAC11 axis in lung epithelial cells . American Journal of Physiology-Lung Cellular and Molecular Physiology 318:2, pages L252-L263.
Crossref
Xing An, Chuantao Zhang, Xiangwen Weng, Wei Xiao, Zengtao Sun, Zhu Zeng & Qingsong Huang. (2020) C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. Medicine 99:29, pages e21152.
Crossref
Velin Stratev, Valentina Dimitrova & Diana Petkova. (2019) COPD and Comorbidities: Relating Mechanisms and Treatment. Current Respiratory Medicine Reviews 15:2, pages 90-101.
Crossref
Alejandra Cañas-Arboleda, Catalina Hernández-Flórez, Javier Garzón, Claudia Marcela Parra-Giraldo, Juan Felipe Burbano & José Enrique Cita-Pardo. (2019) Colonization by Pneumocystis jirovecii in patients with chronic obstructive pulmonary disease: association with exacerbations and lung function status. The Brazilian Journal of Infectious Diseases 23:5, pages 352-357.
Crossref
Katy C. Norman, Christine M. Freeman, Neha S. Bidthanapally, MeiLan K. Han, Fernando J. Martinez, Jeffrey L. Curtis & Kelly B. Arnold. (2019) Inference of Cellular Immune Environments in Sputum and Peripheral Blood Associated with Acute Exacerbations of COPD. Cellular and Molecular Bioengineering 12:2, pages 165-177.
Crossref
Jonathan A. Kropski, Bradley W. Richmond, Christa F. Gaskill, Robert F. Foronjy & Susan M. Majka. (2017) Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series). Pulmonary Circulation 8:1, pages 1-18.
Crossref
Marc Miravitlles, Ana Menezes, Maria Victorina López Varela, Alejandro Casas, Luis Ugalde, Alejandra Ramirez-Venegas, Laura Mendoza, Ana López, Fernando C. Wehrmeister, Filip Surmont & Maria Montes de Oca. (2018) Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study. Respiratory Medicine 134, pages 62-69.
Crossref
Corry-Anke Brandsma, Maaike de Vries, Rita Costa, Roy R. Woldhuis, Melanie Königshoff & Wim Timens. (2017) Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?. European Respiratory Review 26:146, pages 170073.
Crossref
Marc Miravitlles, Juan José Soler-Cataluña, Myriam Calle, Jesús Molina, Pere Almagro, José Antonio Quintano, Juan Antonio Trigueros, Borja G. Cosío, Ciro Casanova, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano & Julio Ancochea. (2017) Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable. Archivos de Bronconeumología 53:6, pages 324-335.
Crossref
Marc Miravitlles, Juan José Soler-Cataluña, Myriam Calle, Jesús Molina, Pere Almagro, José Antonio Quintano, Juan Antonio Trigueros, Borja G. Cosío, Ciro Casanova, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano & Julio Ancochea. (2017) Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Chronic Obstructive Pulmonary Disease. Archivos de Bronconeumología (English Edition) 53:6, pages 324-335.
Crossref
. (2017) Tratamiento de la EPOC Estable. Archivos de Bronconeumología 53, pages 23-33.
Crossref
Marc Miravitlles & Juan José Soler-Cataluña. (2017) GOLD en 2017: una visión desde la Guía Española de la EPOC (GesEPOC). Archivos de Bronconeumología 53:3, pages 89-90.
Crossref
Marc Miravitlles & Juan José Soler-Cataluña. (2017) GOLD in 2017: A View From the Spanish COPD Guidelines (GesCOPD). Archivos de Bronconeumología (English Edition) 53:3, pages 89-90.
Crossref
Aleksandr I. Sinopal’nikov. (2017) Levofloxacin: the role and significance in the treatment of lower respiratory tract infections. Clinical Medicine (Russian Journal) 94:11, pages 851-860.
Crossref
Erhan Ugurlu, Emine Kilic-Toprak, Ilknur Can, Ozgen Kilic-Erkek, Goksel Altinisik & Melek Bor-Kucukatay. (2017) Impaired Hemorheology in Exacerbations of COPD. Canadian Respiratory Journal 2017, pages 1-8.
Crossref